1. GLP‐1 agonists for obesity and type 2 diabetes in children: Systematic review and meta‐analysis
   Karan R. Chadda et al, 2021, Obesity Reviews CrossRef
2. Efficacy and safety of liraglutide for weight management in children and adolescents: a systematic review and meta-analysis of randomized controlled trials
   Hao Gou et al, 2023, European Journal of Pediatrics CrossRef
3. The effects of incretin‐based therapies on weight reduction and metabolic parameters in children with obesity: A systematic review and meta‐analysis
   Jian‐Ying Wang et al, 2024, Obesity Reviews CrossRef
4. Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity
   Mojca Jensterle et al, 2023, Hormone Research in Paediatrics CrossRef
5. Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force
   Sanjay Kalra et al, 2019, Diabetes Therapy CrossRef
6. Liraglutide suppresses obesity and promotes browning of white fat via miR-27b in vivo and in vitro
   Xing Wang et al, 2021, Journal of International Medical Research CrossRef
7. Efficacy and safety of glucagon-like peptide-1 receptor agonists on prediabetes: a systematic review and meta-analysis of randomized controlled trials
   Hazem Mohamed Salamah et al, 2024, Diabetology & Metabolic Syndrome CrossRef
8. Liraglutide in adolescents with simple obesity and gastrointestinal comorbidities: treatment experience
   A. V. Vitebskaya et al, 2023, Obesity and metabolism CrossRef
9. Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis
   Paul M. Ryan et al, 2021, The Journal of Pediatrics CrossRef